A CTO running a PE-backed company six months post-funding held a public AMA on Hacker News, surfacing real founder concerns about scaling, capital allocation, and market execution. For healthcare AI vendors, this signals the growing scrutiny PE firms place on clinical validation and unit economics as they deploy capital into the space. Healthcare-specific implications are sharp: PE investors backing EHR integrations, clinical decision support, or RCM automation expect faster regulatory clearance, faster customer acquisition, and faster proof of value in workflows. The velocity and author diversity around this topic suggest healthcare founders are actively comparing notes on PE dynamics, making it critical for consultants advising on funding strategy to understand current expectations around clinical evidence and revenue milestones.